key: cord-0738440-uuo1o71k authors: Fang, Liang; Yu, Quanmei; Yin, Fanfan; Yu, Jiakuai; Zhang, Yunfei; Zhang, Yu; Zhu, Daomin; Qin, Ximing title: Combined cortisol and melatonin measurements with detailed parameter analysis can assess the circadian rhythms in bipolar disorder patients date: 2021-06-06 journal: Brain Behav DOI: 10.1002/brb3.2186 sha: d4ce29fc94900fb831cd618626f30578e0649b26 doc_id: 738440 cord_uid: uuo1o71k OBJECTIVES: Bipolar disorder (BD) is a common chronic mental illness. The circadian clock disorder shows a significant correlation with the pathogenesis, phenotype and recurrence of BD. We aim to evaluate non‐invasive methods that can comprehensively assess the circadian rhythmicity in BD patients. METHODS: We non‐invasively collected salivary samples and oral epithelial cells from recruited subjects. Then the levels of cortisol and melatonin in saliva were measured and the circadian clock gene expressions (PER2 and BMAL1) of epithelial cells were analyzed. Due to the disease characteristics of the manic patients who were difficult to cooperate with the protocol, only one patient at manic episode was recruited. Besides, 11 patients at the depressive episode, 15 healthy controls and four patients at recovery stage were recruited. RESULTS: Our results exhibited that the peak phase of cortisol level mainly manifested around 8:00 a.m., and the maximal melatonin level reached around 5:00 a.m. The phase of cortisol in patients with depression did not change significantly, but the level of cortisol decreased significantly, while the phase of melatonin level moved forward about 2.5 hr. Furthermore, the levels and phases of cortisol and melatonin in recovery patients tended to be similar to those of healthy controls. CONCLUSIONS: With detailed parameter analysis, the combined detection of melatonin and cortisol can better judge the biological clock disorder of bipolar patients. The circadian rhythms of patients at the recovery stage tend to be normal. The clock gene expression examination needs strict quality control and more investigations before being applied to assess human circadian rhythms. Bipolar disorder (BD in the following text) is one of the major mental disorders, which manifests in repeated manic and depressive behaviors. At present, about 1%-4% of the world's population suffers from BD disease that often has an evident appearance from adolescence to early adulthood (Fava et al. 2010; Merikangas et al., 2007) . BD is a complex disease caused by heredity and environmental susceptibility factors (Lichtenstein et al., 2009) . Among these factors, the abnormal circadian rhythm showed a significant correlation with the pathogenesis, phenotype, and recurrence of the disorder. The internal circadian clock controls the daily physiological activities and energy metabolism of the organism from single-cell level to multiple tissue levels (Balsalobre et al., 1998; Giebultowicz, 2004) . Some evidence show that the onset of bipolar disorder is related to the mutation of clock-related genes. For example, single nucleotide polymorphisms (SNPs) of NR1D1/2, ROR, and CLOCK genes were reported to show relations to the onset of BD (Benedetti et al. 2003; Milhiet et al., 2014; Milhiet et al., 2011) . Therefore, the pathogenesis of BD may be closely related to the abnormal biological clock system of the patients. Light intensity, temperature changes, and other environmental factors could synchronize the body's biological clock, which is called entrainment (Hastings et al., 2003; Pittendrigh, 1960) . In these environmental cues, the light/dark cycle is the strongest cue to entrain the clock (Turek et al., 1996) . The suprachiasmatic nucleus (SCN) located in the hypothalamus is the pacemaker of the biological clock and the master of the biological clock in mammals that is directly entrained by the light/dark cycle (Hastings et al., 2003) . The peripheral circadian clocks exist in various tissues and organs of the body, such as liver, kidney, skin, and so on, which are regulated and coordinated by SCN. Manic symptoms can circulate periodically or even seasonally, which supports that its pathological state has a relationship with environmental cues. In addition, normal sleep-wake cycle and social timing factors are often essential for emotional stability. When these rhythms are destroyed, a manic episode will be triggered (Saeed et al., 1998) . More and more evidence show that the disorder of circadian rhythm is closely related to the pathogenesis and manifestation of BD (Boivin, 2000; Lai et al., 2015; Nováková et al., 2015) . Some other research evidence show that the circadian clock of BD patients is out of sync with the external environment, indicated by measuring the blood cortisol or melatonin levels from BD patients (Cervantes et al., 2001; Kennedy et al., 1996; Yang et al., 2009 ). Thus, one can conclude that there are associations between disturbed circadian rhythms and bipolar disorders during both depression and mania episodes. Importantly, some exciting preliminary evidence suggests that interventions in light-dark cycles and sleep-wake rhythms could potentially enhance the treatments of BD diseases (Frank et al., 2005) . Thus, it is critical to assess the circadian rhythm of the BD patients, in order to examine the pathophysiology of the disease. In general, repeated blood samplings are carried out to measure the circulating hormones (such as prolactin, corticotropin, cortisol, thyrotropin, and melatonin) to assess the circadian rhythm (Claustrat et al., 1984; Klerman et al., 2002; Linkowski et al., 1987; Cauter et al., 1996) . In some cases, polysomnography studies and sleep logs are recorded to measure the rhythm (Roenneberg et al., 2007) . However, repeated blood sampling is not feasible to carry out on patients with severe depression or mania since it is invasive and patients may not be able to tolerate such a procedure. Questionnaire studies are too subjective to reflect the endogenous status of the patients. Recently, single or multiple sample estimations of internal circadian rhythms were established by analysis of blood metabolites or gene expression, but these methods are still at a very early stage and are not adapted for clinical usage (Ueda et al., 2004) . Therefore, non-invasive measurements are required to assess the circadian rhythm of the patients. In the past decades, non-invasive assays have been applied to measure the circadian rhythms of human beings, such as measuring the saliva cortisol (Kirschbaum & Hellhammer, 1994) , saliva melatonin (Zhou et al., 2003) , and gene expression patterns from buccal cells (Cajochen et al., 2006; Cho et al., 2016; Nováková et al., 2015) . BD patients have been suggested by these studies, but inconsistent results have been reported. Some research has demonstrated that saliva melatonin levels were found to be decreased in patients with BD and the dim light melatonin onset (DLMO) was found to be later than controls (Parry & Newton, 2001; Robillard et al., 2013) . Others reported increased cortisol levels while some others did not find such differences (Cervantes et al., 2001; Deshauer et al., 2006; Havermans et al., 2011) . Others evidence shows phase advance in the BD patients at mania but not at depression episode (Nováková et al., 2015) . Moreover, Huang et al. reported lower cortisol expression and a blunted cortisol awakening response (CAR) in depressive BD patients (Huang et al., 2017) . The exact profiles of these circadian biomarkers in the BD patients which could be important for the treatments of BD diseases remain elusive. The aim of this study was to evaluate the valid examinations that can measure the circadian rhythm from BD patients using noninvasive sample collections. The main subjects we recruited for this study were BD patients at the depression episode and a few of them were at the recovery phase. Then we studied the daily pattern of the potential circadian rhythms of cortisol, melatonin, and clock gene expression within the recruited BD patients. We found that the rhythms of melatonin and cortisol are robust in control groups, depressive BD patients, and BD patients at recovery phase. These rhythms showed different patterns in depressive BD patients from the healthy control group, while they displayed similar profiles with those of healthy controls and recovery BD patients. However, the gene expression pattern in buccal mucosa cells cannot be validated since the quality of extracted RNA is low, which needs further examination. Our data suggest that the combination of measuring cortisol and melatonin could be a solid and comprehensive examination to distinguish depressive BD patients from healthy controls while measuring the gene expression level should be a very cautious way to undertake. The patients with BD were recruited from inpatients at the Department of Sleep Disorders, Psychological Hospital Affiliated to Anhui Medical University. From March 2019 to February 2020, the study included 11 patients with bipolar disorder at depressive stages who were hospitalized in the Anhui Medical University's affiliated psychological hospital (three males and eight females with the average HAMD scores 30.83 ± 3.971, indicating that they were at moderate to severe depressive episodes), one BD patient at mania episode, and four BD patients at recovery stage (three males and and female), who were recruited from outpatient clinics through telephone calls. At the same time, 15 healthy controls (six males and nine females) were recruited from the community. The ages of the participants were 30.81 ± 12.913 (mean ± SD) years old for patients and 25.53 ± 8.903 years old for healthy controls, respectively. There were no significant differences with respect to characteristics including age and sex among groups (Table 1) ability, organic brain injury, or other major psychiatric disorders were excluded from the present study, including those who have received electroconvulsive therapy or transcranial magnetic stimulation within 3 months and are unable to take medication as prescribed. All participants underwent screening to exclude past or present major medical disorders such as diabetes, thyroid disease, hypertension, heart disease, narrow-angle glaucoma, epilepsy, dementia, and other neurological diseases and history of pregnancy or breastfeeding women, or those planning to become pregnant. At the same time, our exclusion criteria include no smoking, no caffeinated drinking, and no medications of hydrocortisone or prednisolone, etc. Other medications are allowed during the research. Clinical symptoms were evaluated using the Yang's Mania Rating Scale (YMRS) (Young et al., 1978) , the 24-item Hamilton Depression Scale (HAMD) (Hamilton, 1980) , and the Hamilton Anxiety Scale (HAMA). Participants were informed of the purpose and procedures of the study. After fully explaining and fully understanding the study, all participants provided informed written consent before recruitment. The research plan was approved by the Institutional Review University. Patients with bipolar disorder were recruited and diagnosed by Psychological Hospital affiliated to Anhui Medical University during periods of depression or manic episodes. The normal control group had excluded the history of personal or family psychosis. The subjects had regular sleep/awakening schedules during the week before sampling. As indicated in Figure 1 , the sleep habits of hospitalized subjects were controlled by the regular ward routine, that is, they went to bed at 22:00 and waked up at 06:00 a.m. Light exposure was also controlled by the ward routine, that is, the lights were turned off from 22:00 to 06:00 (Light intensity does not exceed 20 lux), and turned on from 06:00 to 22:00(light intensity is about 400 lux). All subjects avoid prolonged access to natural daylight, and need to adapt to the ward for one day, and oral mucosal cells were collected on the second and third days. Samples are collected by well-trained nurses. Subjects are not allowed to drink alcoholic and caffeinated beverages during the sampling period, use gum or brush their teeth frequently. After providing saliva (≥1 ml) directly into Salivettes (Sarstedt AG & Co) which were stored at −40°C until detection, buccal epithelial cells were collected and immediately placed into RNA lysis solution (Sigma-Aldrich) and stored at −40°C until detection. The nighttime sample collections were performed by well-trained nurses without additional light exposure (Light intensity does not exceed 20 lux), under light as dim as possible, but these collections did require brief awakenings, and it is known that patients with acute psychiatric illnesses usually have disturbed sleep. After a few sampling, the recruited subjects could not tolerate the procedure of collecting buccal epithelial cells for two consecutive days. Thus, the saliva samples were collected for consecutive 2 days, but the buccal cells were collected for 1 day. Salivary cortisol was assayed using Salivary Cortisol ELISA (DRG International, Inc), and used in strict accordance with the product instructions. The analytical sensitivity is 0.09 ng/ml. The intra-assay coefficient of variation is 6.1% for 3.08 ng/ml samples and 2.6% for 20.14 ng/ml samples. The inter-assay coefficient of variation is 13.6% for 0.64 ng/ml samples and 4.3% for samples of 19.78 ng/ml. The salivary cortisol level at each time point is expressed in ng/ml and expressed as the mean ± SEM. Salivary melatonin was assayed using Melatonin direct Saliva ELISA (IBL International GmbH) and used strictly in accordance with product instructions. The analytical sensitivity was 0.3 pg/ml. The intraassay coefficient of variation is 10.8% for 1.7 ± 0.2 pg/ml samples and 8.7% for 33.2 ± 2.9 pg/ml samples. The inter-assay coefficient of variation is 12.7% for 2.1 ± 0.3 pg/ml samples and 13.0% for the sample of 14.7 ± 1.9 pg/ml. The melatonin levels at each time point are expressed in pg/ml, and expressed as mean ± SEM. The expression levels of circadian rhythm-related genes PER2 and TA B L E 2 Numbering system to recruited subjects F I G U R E 1 Schematic of the protocol design. The figure illustrates the protocol used in this study. We have two isolated sleep monitoring laboratories which have its light on at 06:00 (indicated by the blue arrow) and light off at 20:00 (indicated by the dark arrow). Recruited BD patients and healthy controls who are maintaining a 22:00-06:00 sleep schedule. In the laboratory, subjects can maintain their normal activity without using electronic books or smart telephones during waking time. We believe that this situation is as close to the real situation as possible. The subjects took 1 day to get adapted to the laboratory environment, and saliva samples were samples at indicated time points (08:00, 11:00, 14:00, 19:00, 22:00, 01:00, and 05:00) in the two consecutive days. Since most subjects cannot tolerate the procedure of buccal mucosa sampling, this process takes 1 day at indicated time points. Mealtime (normal meal with low-calorie intake) was controlled during the whole procedure. Light levels were maintained at about 400 lux during the light on period and less than 20 lux during the light-off The 24-hr saliva melatonin and cortisol concentration levels of each Due to irreversible reasons such as experimental operation (calculated value is out of the range of the standard curve) and sample quality, data at some time points are either dropping or missing. Participants who have missing data at more than four time points are not included in the final statistical analysis. Participants who do not perform statistical analysis include LA11, LA12, LA13, LB15 (cortisol data) and LA11, LA14, LA15, LB8, LB12, LB13,LB16 (melatonin data). There is only one person in the manic phase of bipolar disorder, which is not statistically significant, so statistical analysis is not performed. 3.1 | Daily salivary cortisol profiles are similar in healthy controls and BD patients in the depressive episode, but the peak cortisol level of BD patients is lower than healthy controls The cortisol profiles of all subjects, including healthy controls and recruited BD patients, showed significant circadian rhythms when the cortisol contents in two consecutive days collected saliva were Similarly, the melatonin profiles of all subjects, including healthy controls and recruited BD patients, showed significant circadian rhythms. The cosine analysis (see M&M) exhibited significant fits to each individual, with a better fitness than that of cortisol profiles (R 2 values are significantly higher, Figures S4,S6) . Averaged data of the melatonin profiles were demonstrated according to the three groups: healthy controls (Control, Figure 4a ), BD patients in the depressive episode (Depression, Figure 4b ), and BD patients in the recovery phase (Recovery, Figure 4c) . The other three parameters of the slopes were not different in three groups (Figures 5j-l) . In order to better present the peak phases of the salivary cortisol and melatonin in recruited subjects, Rayleigh plots were applied to (Table 3) . When RNAs were extracted from collected buccal mucosa cells, though total quantities were comparable to these RNAs extracted from 1 × 10 5 mucosa cells, the qualities did not reach the standard. Both RIN and 28S/18S values were low, indicating (Table 3) . Nevertheless, we further tested the BMAL1/PER2 expression patterns of collected one-day samples. The acrophases of the gene expression patterns were evenly distributed in 1 day, and the amplitudes showed large variances ( Figures S7 and S8 ). Based on our observations, we highly recommend special cares are required for this gene expression method used for the assessment of circadian rhythms in humans. This study demonstrates that the depression episodes in BD patients are associated with disturbed circadian rhythms through investigating the circadian biomarker cortisol and melatonin non-invasively. We clearly observed ~2.5 hr phase advances of melatonin rhythms in the BD patients at depressive episodes (Figures 4, 5b, 6b) we observed that the amplitude of cortisol is significantly damped in the depressive BD patients than that in the healthy controls ( Figure 3f,g) . Not only because of the difficulty to recruit BD patients at mania episode but also due to the prevalent COVID-19, we only had one mania patient recruited for this study. Though not statistically representative, this mania patient showed highly advanced acrophase of melatonin ( Figure S9 ). The melatonin phase in this patient was >7 hr advanced compared to the controls. Very interestingly, the amplitude of cortisol level and the phase of melatonin level of BD patients at recovery phase were comparable to these in controls (Figures 3f, 5b, 6c, d) , which indicate corrected circadian rhythms may reflect a proper treatment. Previous studies have suggested that disturbance of circadian rhythms is a possible cause of BD (Duarte Faria et al., 2015; Gonzalez, 2014) . Most studies concentrated on measuring only cortisol level or only melatonin level and inconsistent results were reported (Deshauer et al., 2006; Havermans et al., 2011; Parry & Newton, 2001) . There has no measurement of circadian rhythms of both cortisol and melatonin through non-invasive collections with detailed parameter analysis including not only periods, amplitudes, but also the rising and decreasing slopes of each hormone. This study provides detailed parameter analysis to comprehensively assess the rhythmicity and reveals that the decreasing slopes of melatonin during daytime were smaller in depressive BD patients ( Figure 5 ). This detailed parameter analysis provides more information to assess the circadian rhythm of a given subject. For example, averaged 24-hr levels, maximal levels, ranges, two-day differences, and slopes of both daytime and night showed no difference between healthy controls and recovery groups (Figures 3,5) , indicating an effective therapy results in those patients. Thus, this method may be used to objectively evaluate whether a BD patient is treated to a satisfied level. One potential weakness of this method is that it will be difficult to compare the level of cortisol or melatonin when large numbers of samples are measured, which need internal controls from batch to batch. Salivary cortisol concentrations can reflect plasma unbound cortisol levels and there was almost no time lag between salivary cortisol and plasma cortisol values (Kirschbaum & Hellhammer, 1989) . Similarly, salivary melatonin concentrations show strong correlations with plasma levels, though salivary melatonin is about three times less than that in plasma (Ito et al., 2013 (Figures 4d,5b) , while the patients with other depressive symptoms showed delayed or lengthened circadian rhythm (Robillard et al., 2013) . This difference indicates different pathogenesis of BD from other depressions, though they may appear similar depressive symptoms. Taking consideration of different phase angles in BD from other depressions is very interesting, a recent study has classified patients with depressive disorders into two subgroups based on the phase angle between dim light melatonin onset and core body temperature (Robillard et al., 2018) . Also, the relative early phase of the melatonin in depressive BD patients may explain more sleepiness in BD patients at the depression episodes. The only one mania patient showed a very large phase advance, compared to controls. Whether this represents shorter circadian cycles in mania BD patients cannot be proven in this study. We will recruit more patients in our future study. Previous studies have reported suppressed melatonin levels in the bipolar patients (Lam et al., 1990) , which we did not observe in this study. This difference might be due to different sampling times over 1 day. Besides cortisol and melatonin, we attempted to measure gene expression levels using canonical circadian genes, BMAL1 and PER2. Unfortunately, our results showed low RIN values and very low 28S/18S values of the RNAs extracted from buccal mucosa cells. RNAs extracted from similar small amount of cultured cells (1 × 10 5 ) showed good quality both in RIN and in 28S/18S values. These measurements highly suggest instability or lack of intact in these mucosa extracted RNAs, since RNase and other nuclease are abundantly present in saliva (Kumar et al., 2006) . Though previous studies have reported using gene expression profiles to assess the circadian rhythms (Bjarnason et al., 2001; Cho et al., 2016; Jud et al., 2009; Koshy et al., 2019) , none of them have done RNA stability tests before using cDNA reversely transcribed from extracted RNAs. Thus, we highly recommend that special attention and more controlled experiments are required to further solidify the circadian rhythm assessment using the gene expression method. In our measurement protocol, recruited controls and patients are in an environment that simulates their normal living conditions. Our exclusion criteria include no smoking, no caffeinated drinking, and no medications of hydrocortisone or prednisolone, etc. Other medications are allowed during the research. Saliva collections are non-invasive and can be accepted by most human subjects. Therefore, patients under prescription and home care could collect their saliva samples and store in proper ways, and send these samples to the hospital for assessment of their circadian rhythms. We hope this objective measurement can precisely assess the circadian rhythms of these patients who may need future light therapy to treat their disorders. Although our results suggest that combined measurements of cortisol and melatonin can be considered as a biomarker to distinguish depressive BD patients and controls, our studies have limitations. First, the number of recruited subjects is relatively small. Second, we did not successfully recruit BD patients at the mania episode, which might provide more information if more mania patients are assessed. Though the number of recruited subjects is small, other studies support our findings that the phases of depressed patients are advanced than those in healthy controls (Gwirtsman et al., 1989) . We would perform more studies to further understand the relationships between circadian clocks and different episodes in BD disease. This work was financially supported by grants from the Provinciallevel Key R&D Programmes (201904a07020015 to D.Z) and Anhui Provincial Natural Science Foundation (1608085MH212, 2008085MC68 to X.Q). This work was also supported by the grant from the National Natural Science Foundation of China (32071158 to X.Q). Yunfei Zhang is supported by the Research Start Grant from Anhui University (Y040418157). We are grateful to the hospital staff for collecting samples from the recruited subjects. We are also grateful to the staff for providing technical support with using the facility of Institute of Physical Science and Information Technology at Anhui University. The authors declare that they have no conflicts of interest. D. Z. and X.Q. conceived and designed research; J.Y. and Y. Z. collected the samples from recruited subjects; L.F., Q.Y., F.Y., J.Y, performed research; all authors were involved in analyzing data; L.F. wrote original draft, D.Z. and X.Q. writing -review & editing. The peer review history for this article is available at https://publo ns.com/publo n/10.1002/brb3.2186. Ximing Qin https://orcid.org/0000-0003-2496-2434 Balsalobre, A., Damiola, F., & Schibler, U. (1998) . A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell, 93 (6), 929-937. https://doi.org/10.1016/S0092 -8674(0 0)81199 -X Benedetti, F., Serretti, A., Colombo, C., Barbini, B., Lorenzi, C., Campori, E., & Smeraldi, E. (2003) . Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression. Circadian expression of clock genes in human oral mucosa and skin: Association with specific cell-cycle phases Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders Evening exposure to blue light stimulates the expression of the clock gene PER2 in humans Circadian secretion of cortisol in bipolar disorder Molecular circadian rhythm shift due to bright light exposure before bedtime is related to subthreshold bipolarity A chronobiological study of melatonin and cortisol secretion in depressed subjects: Plasma melatonin, a biochemical marker in major depression Salivary cortisol secretion in remitted bipolar patients and offspring of bipolar parents Biological rhythms in bipolar and depressive disorders: A community study with drug-naive young adults The importance of irritability as a symptom of major depressive disorder: Results from the National comorbidity survey replication Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder Chronobiology: Biological timekeeping The relationship between bipolar disorder and biological rhythms Apparent phase advance in diurnal MHPG rhythm in depression Rating depressive patients A clockwork web: Circadian timing in brain and periphery, in health and disease Patterns of salivary cortisol secretion and responses to daily events in patients with remitted bipolar disorder Cortisol awakening response in patients with bipolar disorder during acute episodes and partial remission: A pilot study Relationships between salivary melatonin levels, quality of sleep, and stress in young Japanese females Age-dependent alterations in human PER2 levels after early morning blue light exposure Nocturnal melatonin and 24-hour 6-sulphatoxymelatonin levels in various phases of bipolar affective disorder Salivary cortisol in psychobiological research: An overview Salivary cortisol in psychoneuroendocrine research: Recent developments and applications Comparisons of the variability of three markers of the human circadian pacemaker Disruption of central and peripheral circadian clocks in police officers working at night Validity of messenger RNA expression analyses of human saliva Investigation of associations between NR1D1, RORA and RORB genes and bipolar disorder Melatonin suppression in bipolar and unipolar mood disorders Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: A population-based study 24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: Effect of antidepressant treatment Lifetime and 12-month prevalence of bipolar spectrum disorder in the National comorbidity survey replication Circadian abnormalities as markers of susceptibility in bipolar disorders Circadian biomarkers, circadian genes and bipolar disorders Methods for cosinor-rhythmometry The circadian system of patients with bipolar disorder differs in episodes of mania and depression Chronobiological basis of femalespecific mood disorders Circadian rhythms and the circadian organization of living systems Prolonged grief disorder: Psychometric validation of criteria proposed for DSM-V and ICD-11 Circadian rhythms and psychiatric profiles in young adults with unipolar depressive disorders Sleep-wake cycle and melatonin rhythms in adolescents and young adults with mood disorders: Comparison of unipolar and bipolar phenotypes Epidemiology of the human circadian clock Seasonal affective disorders Handbook of physiology: Adaptation to the environment Molecular-timetable methods for detection of body time and rhythm disorders from single-time-point genomewide expression profiles Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol Assessment of circadian function in fibroblasts of patients with bipolar disorder A rating scale for mania: Reliability, validity and sensitivity Alterations in the circadian rhythm of salivary melatonin begin during middle-age Additional supporting information may be found online in the Supporting Information section.